Cyril Titeux is Company Group Chairman, Johnson & Johnson Innovative Medicine Asia Pacific, and a member of the Innovative Medicine Group Operating Committee (GOC).
Cyril joined Johnson & Johnson in 1997, gaining sales, marketing, and leadership experience across therapeutic areas with Janssen France. He relocated to the United States with his wife and four children in 2005, to serve as Global Marketing Leader for Virology.
After returning to the EMEA (Europe, Middle East, and Africa) region, Cyril served as Managing Director of Janssen Austria, becoming President of Janssen France in 2015. Cyril later became Vice President, EMEA Strategy Organization where he led the regional commercial, medical affairs and market access functions. Most recently, Cyril held the role of Vice President and Managing Director of Mid-Sized Markets, where he led teams across 31 markets to deliver significant growth, doubling the size of the business over five years. During this time, Cyril also served as Vice-Chair of the EFPIA European Markets Committee.
After graduating as a Veterinary Doctor from the National Veterinary School of Maisons-Alfort in France, Cyril earned his MBA from the HEC Business School in Paris. He started his pharmaceutical career with Eli Lilly, where he held various positions in sales, market research and marketing.
As a cycling enthusiast, Cyril initiated ‘Cycling for Children,’ gathering 3,500 colleagues across J&J EMEA to support children in need this year.
Cyril is an authentic, Credo-based leader known for his commitment to delivering strong results through high performing, collaborative teams. He is skilled at attracting and developing talent and building an inclusive and engaged culture.